Planning a Safe Reopening with Visitor Management & Access Control

 

On this episode of ClearTalk, a CTSI podcast, host Tyler Kern was joined by CTSI Vice President Ron Pusey and Health Care Account Executive Mark Thompson for a look at the reopening of the world’s businesses – and what that means for security, surveillance and access control.

The most critical thing leaders can do for their operation, Pusey said, is to ensure that they’ve thoroughly reviewed their plans and policies surrounding these initiatives to ensure that employee buy-in and understanding is high and that they aren’t just purchasing technology for technology’s sake.

“Realistically, without a plan, without a process, without workflow and without policy, it’s very difficult to deploy a technology to solve something when you haven’t planned on how you’re going to use it,” he said.

Key items that need to be determined include which entrances will be open to employees and guest, how the flow of traffic will be managed and monitored, which solutions will assist in that process and, if an organization is planning on solutions that alarm when out-of-range conditions are present, how those alarm conditions will be handled.

In other words, it’s not enough to just have the data – it all has to go somewhere, be analyzed, and be acted upon.

All of these efforts are aimed toward avoiding the one cardinal sin of security and access control – providing a false sense of security for occupants that isn’t backed by thorough technology, integrations and policy.

Throughout the episode, Kern, Pusey and Thompson dove into different applications for different industries, which technologies might suit different plans of action, key questions that operations should be asking when it comes to selecting appropriate technology, and how CTSI can help guide operations to the perfect custom solution.

Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Agentic AI
Agentic AI: IBM is Powering the Next Wave of Autonomous, Intelligent Decision-Making
March 14, 2025

Retail has long embraced automation, but now it’s taking a leap into a new frontier—autonomous decision-making. Enter agentic AI, a technology that doesn’t just automate tasks but makes real-time, intelligent decisions. With major retailers like Walmart integrating AI-driven fulfillment robots and brands such as Bath & Body Works rolling out personalized AI-powered shopping assistants,…

Read More
QSR connectivity
How IBM and Hughes Are Powering the Future of QSR Connectivity & Fast Food Tech
March 14, 2025

Quick service restaurants (QSRs) are under increasing pressure to enhance speed, efficiency, and customer experience—all while managing a growing network of digital systems. From AI-powered ordering kiosks to real-time kitchen automation, modern QSRs are more connected than ever. The restaurant AI market was valued at $9.68 billion in 2024, and expected to reach $49 billion…

Read More
Trade tariffs
From Asia to the World: How Dimerco is Helping Businesses Navigate New Trade Tariffs and Supply Chain Shifts
March 13, 2025

The global supply chain is once again at a crossroads, with shifting trade policies, geopolitical tensions, and economic fluctuations shaping the way goods move across the world. The looming threat of new trade tariffs on imports from Asia, combined with fluctuating shipping rates, is creating a challenging landscape for logistics professionals. With businesses re-evaluating…

Read More
sterile compounding
Sterile Compounding and Contamination Control with Abby Roth
March 11, 2025

In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…

Read More